This Enforcement Notice concerns advertising for 'Non-invasive Prenatal Testing' (NIPT), which is a type of screening for genetic conditions using maternal blood to examine foetal DNA.

The ASA recently ruled that commonly cited statistical claims such as 95%+ "Detection Rates" are likely to mislead customers. CAP's Enforcement Notice sets out the dos and dont's of advertising NIPT services.


More on